Inventor · disambiguated record
Dario G. Gomez
Also filed as: GOMEZ DARIO G
15 granted patents·6 pending applications·230 citations·filing 2001–2021
92Inventor score
Top patents by PatentIndex Score
21 records- 0197US7091232B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2003·Granted Aug 15, 2006·112 cites·3 claims
- 0294US6841684B2Imidiazoles having reduced side effectsALLERGAN INC·Filed 2001·Granted Jan 11, 2005·72 cites·18 claims
- 0390US7345077B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2005·Granted Mar 18, 2008·12 cites·20 claims
- 0488US7419994B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2006·Granted Sep 2, 2008·8 cites·16 claims
- 0587US8063231B2Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2009·Granted Nov 22, 2011·4 cites·1 claims
- 0684US8329918B2Selective alpha 2B/2C agonistsNGUYEN PHONG X·Filed 2010·Granted Dec 11, 2012·7 cites·2 claims
- 0782US8071636B2Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2009·Granted Dec 6, 2011·4 cites·17 claims
- 0882US8063087B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compoundsCHOW KEN·Filed 2008·Granted Nov 22, 2011·4 cites·9 claims
- 0980US2023062049A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2021·Application pending·0 cites
- 1079US9849113B2Methods of treating α adrenergic mediated conditionsALLERGAN INC·Filed 2017·Granted Dec 26, 2017·1 cites·5 claims
- 1177US9572792B2Coumarin compounds as receptor modulators with therapeutic utilityALLERGAN INC·Filed 2015·Granted Feb 21, 2017·2 cites·5 claims
- 1275US9623006B2Methods of treating α adrenergic mediated conditionsALLERGAN INC·Filed 2015·Granted Apr 18, 2017·1 cites·5 claims
- 1373US9034910B2Methods of treating alpha adrenergic mediated conditionsGIL DANIEL W·Filed 2011·Granted May 19, 2015·1 cites·17 claims
- 1472US9073888B2Coumarin compounds as receptor modulators with therapeutic utilityHEIDELBAUGH TODD M·Filed 2010·Granted Jul 7, 2015·2 cites·6 claims
- 1571US2020330428A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2019·Application pending·0 cites
- 1667US2018344692A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2018·Application pending·0 cites
- 1765US2018071260A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2017·Application pending·0 cites
- 1864US8071635B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazole-2-ones and related compoundsCHOW KEN·Filed 2008·Granted Dec 6, 2011·0 cites·9 claims
- 1962US7829587B2Substituted 2-aminotetralin derivatives as selective alpha 2B agonistALLERGAN INC·Filed 2008·Granted Nov 9, 2010·0 cites·19 claims
- 2048US2011178143A1Therapeutic compoundsALLERGAN INC·Filed 2008·Application pending·0 cites
- 2147US2012035235A1Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dario G. Gomez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →